Citations

Clear

3485 citation(s) found for "Sy, Sarah".

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Adekola, Kehinde , Anderson, Larry D. , Costello, Caitlin , Elsedawy, Noura, Faiman, Matthew , Godby, Kelly, Hillengaß, Jens , Holmberg, Leona , Htut, Myo , Huff, Carol Ann , Hultcrantz, Malin , Larson, Sarah , Liedtke, Michaela , Omel, James, Sborov, Douglas W. , Shain, Kenneth H. , Weber, Donna, Berardi, Ryan A., Kumar, Shaji , Holmberg, Leona , Anderson, Larry D , Callander, Natalie S. , Baljević, Muhamed , Campagnaro, Erica , Castillo, Jorge J. , Devarakonda, Srinivas , Garfall, Alfred L. , Kang, Yubin , Martin, Thomas G. , Stockerl‐Goldstein, Keith , Kumar, Rashmi

Mayo Clinic

Journal of the National Comprehensive Cancer Network | January 28, 2022 | Volume: 20 | Issue: 1 | Pages: 8-19

10.6004/jnccn.2022.0002 | PMID 34991075 Get It

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with various plasma cell neoplasms, including multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates/changes specific to the treatment of patients with multiple myeloma in the 2022 version of the guidelines.
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations
Kimple, Adam J. , Senior, Brent A. , Naureckas, Edward T. , Gudis, David A. , Meyer, Ted A., Hempstead, Sarah E. , Resnick, Helaine E. , Albon, Dana , Barfield, Wayne, Benoit, Margo McKenna , Callard, Eliza, Cofer, Shelagh A. , Downer, Veronica S., Elson, E. Claire , Garinis, Angela C. , Halderman, Ashleigh A. , Hamburger, Lisa, Helmick, Meagan , McCown, Michael , McKinzie, Cameron J. , Phan, Hanna , Rodriguez, Kenneth , Severin, Ashley, Shah, Gopi , Shenoy, Ambika , Sprouse, Brittney , Virgin, Frank W. , Woodworth, Bradford A. , Beswick, Daniel , Cofer, Shelagh, Helmick, Meagan , Woodworth, Bradford A , Gudis, David A , Kimple, Adam J , Beswick, Daniel M. , Hamburger, Lisa, McKinzie, Cameron J. , Rubenstein, Ronald C. , Lee, Stella E.

Mayo Clinic

International Forum of Allergy & Rhinology | January 28, 2022 | Volume: 12 | Issue: 9 | Pages: 1089-1103

10.1002/alr.22974 | PMID 35089650 Get It

Abstract Background Cystic fibrosis (CF) is a multisystem disease that often requires otolaryngology care. Individuals with CF commonly have chronic rhinosinusitis but also present with hearing loss and dysphonia. Given these manifestations of CF, otolaryngologists are frequently involved in the care of patients with CF; however, there is limited consensus on optimal management of sinonasal, otologic, and laryngologic symptoms. Methods The Cystic Fibrosis Foundation convened a multidisciplinary team of otolaryngologists, pulmonologists, audiologists, pharmacists, a social worker, a nurse coordinator, a respiratory therapist, two adults with CF, and a caregiver of a child with CF to develop consensus recommendations. Workgroups developed draft recommendation statements based on a systematic literature review, and a ≥80% consensus was required for acceptance of each recommendation statement. Results The committee voted on 25 statements. Eleven statements were adopted recommending a treatment or intervention, while five statements were formulated recommending against a specific treatment or intervention. The committee recommended eight statements as an option for select patients in certain circumstances, and one statement did not reach consensus. Conclusion These multidisciplinary consensus recommendations will help providers navigate decisions related to otolaryngology consultation, medical and surgical management of CF‐CRS, hearing, and voice in individuals with CF. A collaborative and multidisciplinary approach is advocated to best care for our patients with CF. Future clinical research is needed utilizing standardized, validated outcomes with comprehensive reporting of patient outcome, effects of modulator therapies, and genetic characteristics to help continue to advance care, decrease morbidity, and improve the quality of life for individuals with CF.
A Novel USP25::PDGFRA Gene Fusion in a 78 Year Old Patient with a Myeloid Neoplasm
Dalland, Joanna , Blackburn, Patrick R. , Reichard, Kaaren K. , Johnson, Sarah H. , Smadbeck, James B. , Vasmatzis, George , Hoppman, Nicole L., Xu, Xinjie, Greipp, Patricia T. , Peterson, Jess F. , Dalland, Joanna C , Peterson, Jess F , Greipp, Patricia T , Baughn, Linda B.

Mayo Clinic

Laboratory Medicine | January 27, 2022 | Volume: 53 | Issue: 5 | Pages: e134-e138

10.1093/labmed/lmac010 | PMID 35217871 Get It

Abstract The World Health Organization category of myeloid/lymphoid neoplasms with eosinophilia and PDGFRA rearrangements is composed of a heterogeneous group of neoplasms that can present as a myeloproliferative neoplasm, acute myeloid leukemia, myeloid sarcoma, or lymphoblastic leukemia/lymphoma. The overall outcome of these neoplasms is favorable with imatinib therapy. Herein, we describe an adult female patient with a myeloid neoplasm accompanied by eosinophilia and a novel USP25::PDGFRA gene fusion.
Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer
Broeck, Thomas Van den, Moris, Lisa, Gevaert, Thomas, Davicioni, Elai , Boeckx, Bram, Lambrechts, Diether , Helsen, Christine , Handle, Florian , Ghesquière, Bart , Soenen, Stefaan, Smeets, Elien, Eerlings, Roy , Kharraz, Sarah El , Devlies, Wout, Karnes, R. Jeffrey, Lotan, Tamara, Poppel, Hendrik Van, Joniau, Steven , Claessens, Frank , Lambrechts, Diether , El Kharraz, Sarah , Lambrechts, Diether , Davicioni, Elai , Lambrechts, Diether , Joniau, Steven , Ghesquière, Bart , Broeck, Thomas Van den, Moris, Lisa, Gevaert, Thomas, Boeckx, Bram, Helsen, Christine , Handle, Florian , Soenen, Stefaan, Smeets, Elien, Eerlings, Roy , Devlies, Wout , Karnes, R. Jeffrey, Lotan, Tamara, Poppel, Hendrik Van, Claessens, Frank

Mayo Clinic

Molecular Cancer Research | January 26, 2022 | Volume: 20 | Issue: 4 | Pages: 527-541

10.1158/1541-7786.mcr-21-0388 | PMID 35082164 Get It

Abstract Molecular drivers of metastasis in patients with high-risk localized prostate cancer are poorly understood. Therefore, we aim to study molecular drivers of metastatic progression in patients with high-risk prostate cancer. A retrospective matched case-control study of two clinico-pathologically identical groups of patients with high-risk prostate cancer was undertaken. One group developed metastatic recurrence (n = 19) while the other did not (n = 25). The primary index tumor was identified by a uro-pathologist, followed by DNA and RNA extraction for somatic copy-number aberration (SCNA) analysis and whole-transcriptome gene expression analysis. In vitro and in vivo studies included cell line manipulation and xenograft models. The integrative CNA and gene expression analyses identified an increase in Antizyme Inhibitor 1 (AZIN1) gene expression within a focal amplification of 8q22.3, which was associated with metastatic recurrence of patients with high-risk prostate cancer in four independent cohorts. The effects of AZIN1 knockdown were evaluated, due to its therapeutic potential. AZIN1 knockdown effected proliferation and metastatic potential of prostate cancer cells and xenograft models. RNA sequencing after AZIN1 knockdown in prostate cancer cells revealed upregulation of genes coding for collagen subunits. The observed effect on cell migration after AZIN1 knockdown was mimicked when exposing prostate cancer cells to bio-active molecules deriving from COL4A1 and COL4A2. Our integrated CNA and gene expression analysis of primary high-risk prostate cancer identified the AZIN1 gene as a novel driver of metastatic progression, by altering collagen subunit expression. Future research should further investigate its therapeutic potential in preventing metastatic recurrence. Implications: AZIN1 was identified as driver of metastatic progression in high-risk prostate cancer through matrikine regulation.
Clinical Impact Requires Clinical Practice Research
Utianski, Rene L. , Spencer, Trina D. , Utianski, Rene L , Wallace, Sarah E.

Mayo Clinic

Perspectives of the ASHA Special Interest Groups | January 25, 2022 | Volume: 7 | Issue: 3 | Pages: 651-662

10.1044/2021_persp-21-00197 Get It

Purpose: The extent to which research impacts clinical practice is directly related to the availability, accessibility, and relevance of clinical practice research (CPR). The purpose of this article is to describe some of the current barriers to CPR in communication sciences and disorders and review the resources available to support clinical practice researchers. Results: Considerations related to CPR are numerous and relate to its availability, relevance, and accessibility. There are longstanding challenges with the CPR pipeline, which include challenges getting researchers involved in conducting CPR, acquisition of funding to support CPR grant proposals, recognition of the validity and role of less traditional research paradigms in which some CPR is conducted, and publishing and disseminating CPR. The American Speech-Language-Hearing Association (ASHA) has developed a number of resources to support the development, execution, dissemination, and utilization of CPR in speech-language pathology and audiology. Conclusions: Clinicians, researchers, and clinician-scientists alike are encouraged to explore ASHA's CPR resources and initiatives. The outcomes of ASHA programs are encouraging in that researchers who participate in CPR initiatives are largely successful in obtaining funding for CPR. This is promising evidence that the availability, relevance, and accessibility barriers to CPR can be mitigated, which will ultimately lead to improved uptake and impact of CPR.
Delphi Method Consensus on Priority Global Otolaryngology–Head and Neck Surgery Conditions and Procedures
Nuss, Sarah , Patterson, Rolvix H. , Cahill, Gabrielle , Alkire, Blake C., Xu, Mary Jue , Salano, Valerie , Wiedermann, Josh, Okerosi, Samuel , Patterson, Rolvix H

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 25, 2022 | Volume: 167 | Issue: 4 | Pages: 669-677

10.1177/01945998211073705 | PMID 35077240 Get It

ObjectiveThe objective of this study was to develop an international expert consensus on priority otolaryngology–head and neck surgery conditions and procedures globally for which national health systems should be capable of caring.Study DesignThe Delphi method was employed via a multiround online survey administered to attending otolaryngologists in an international research collaborative of >180 otolaryngologists in >40 countries.SettingInternational online survey.MethodsIn round 1, participants listed the top 15 otolaryngologic conditions and top 15 otolaryngology procedures for their World Bank regions. In round 2, participants ranked round 1 responses in order of global importance on a 5‐point Likert scale. In round 3, participants reranked conditions and procedures that did not achieve consensus, defined as 50% of the round 2 Likert responses being ranked as “important” or “very important.” Descriptive statistics were calculated for each round.ResultsThe survey was distributed to 53 experts globally, with a response rate of 38% (n = 20). Fifty percent (n = 10) of participants were from low‐ and middle‐income countries, with at least 1 participant from each World Bank region. Ten consensus surgical procedures and 10 consensus conditions were identified.ConclusionThis study identified a list of priority otolaryngology–head and neck surgery conditions and surgical procedures for which all national health systems around the world should be capable of managing. Acute and infectious conditions with preventative and emergent procedures were highlighted. These findings can direct future research and guide international collaborations.
Comparison of a Focused Family Cancer History Questionnaire to Family History Documentation in the Electronic Medical Record
Clift, Kristin , Macklin‐Mantia, Sarah K. , Barnhorst, Margaret , Millares, Lindsey, King, Zacharay, Agarwal, Anjali , Presutti, R. John , Macklin-Mantia, Sarah, Presutti, Richard J , Clift, Kristin E

Mayo Clinic

Journal of Primary Care & Community Health | January 22, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/21501319211069756 | PMID 35068232 Get It

Introduction: Family health history can be a valuable indicator of risk to develop certain cancers. Unfortunately, patient self-reported family history often contains inaccuracies, which might change recommendations for cancer screening. We endeavored to understand the difference between a patient’s self-reported family history and their electronic medical record (EMR) family history. One aim of this study was to determine if family history information contained in the EMR differs from patient-reported family history collected using a focused questionnaire. Methods: We created the Hereditary Cancer Questionnaire (HCQ) based on current guidelines and distributed to 314 patients in the Department of Family Medicine waiting room June 20 to August 1, 2018. The survey queried patients about specific cancers within their biological family to assess their risk of an inherited cancer syndrome. We used the questionnaire responses as a baseline when comparing family histories in the medical record. Results: Agreement between the EMR and the questionnaire data decreased as the patients’ risk for familial cancer increased. Meaning that the more significant a patient’s family cancer history, the less likely it was to be recorded accurately and consistently in the EMR. Patients with low-risk levels, or fewer instances of cancer in the family, had more consistencies between the EMR and the questionnaire. Conclusions: Given that physicians often make recommendations on incomplete information that is in the EMR, patients might not receive individualized preventive care based on a more complete family cancer history. This is especially true for individuals with more complicated and significant family history of cancer. An improved method of collecting family history, including increasing patient engagement, may help to decrease this disparity.
P446 Long-term Clinical Effectiveness And Stoma Outcome Of Fecal Diversion In Refractory Crohn’s Proctitis
Benammi, Sarah , Calini, Giacomo , Shawki, Sherief , Mathis, Kellie L. , Calini, G , Perry, William , Solafah, A , Larson, David W.

Mayo Clinic

Journal of Crohn's and Colitis | January 21, 2022 | Volume: 16 | Issue: Supplement_1 | Pages: i426-i426

10.1093/ecco-jcc/jjab232.573 Get It

Abstract Background Proctectomy is often recommended when Crohn’s proctitis becomes refractory to medical therapy. However, some surgeons offer a temporary diverting stoma in an effort to avoid a permanent stoma. The long-term efficacy of this approach is not well-established. Our aim was to determine the long-term effectiveness of fecal diversion in patients with refractory Crohn’s proctitis. Methods This retrospective study included all patients with Crohn’s proctitis who underwent formation of a diverting ileostomy or colostomy for refractory disease from, 1998 to, 2019 in Mayo Clinic Rochester MN. Outcomes were disease recurrence, rate of stoma closure, and proctectomy. Univariate comparisons among categorical variables were performed with Pearson’s Chi-square and continuous variables using the student t-test. The cumulative probability of stoma closure was performed with a Kaplan Meier log-rank analysis. Multivariable analysis of risk factors for proctectomy and permanent stoma was achieved with logistic regression. Results Ninety-seven patients (55.7% female) were included. Ileostomy was the most common stoma type (88.7%, n=86), and colostomy was (11.3%, n=11) (Table.1). Median follow-up was, 4 years (range, 0–14). Active Crohn’s at follow-up was reported in, 68.1%. Only, 41.2% of patients underwent attempt at stoma reversal, and, 42.3% required a proctectomy (median, 19.5 months after diversion). At last follow-up, 29.9% were stoma-free, 42.3% had a new permanent stoma, and, 27.8% had the original diverting stoma (Fig.1). The multivariable predictors of proctectomy and permanent stoma were the recurrence of active CD after diversion and the need for other CD-related surgery following stoma creation (Table.2). The limitations of the study are its small sample size and its retrospective nature. The cumulative probability of stoma closure was performed with a Kaplan Meier log-rank analysis (Fig.2). Conclusion Diversion is effective at alleviating symptoms of Crohn’s proctitis in selected patients but does not significantly change disease outcome. Only a small number can avoid a long-term stoma.
P265 Open approach for ileocolic resection in Crohn’s disease in the era of minimally invasive surgery: indications and perioperative outcomes in a referral centre
Calini, Giacomo , Benammi, Sarah , Merchea, Amit , Mathis, Kellie L. , Larson, Dirk, Calini, G , Solafah, A , Aziz, Mohamed A. Abd El , Behm, Kevin T.

Mayo Clinic

Journal of Crohn's and Colitis | January 21, 2022 | Volume: 16 | Issue: Supplement_1 | Pages: i305-i305

10.1093/ecco-jcc/jjab232.392 Get It

Abstract Background Minimally invasive surgery (MIS) is the first-line approach for ileocolic resection in patients with Crohn’s disease (CD) and it is safe and feasible even in complex cases. However, an open approach is still required, but indications to open ileocolic resection for CD are not well described. Methods All consecutive adult patients with CD who underwent elective ileocolic resection in the Departments of Colon and Rectal Surgery at Mayo Clinic Rochester, Minnesota and Jacksonville, Florida between September 2014 and March 2021 were included and divided into “open” and “MIS” groups. Open approach was defined as upfront laparotomy, MIS included laparoscopic and robotic approaches, and conversion was defined as incision made earlier than planned. Indications to open approach were retrospectively reviewed by two authors, and any incongruity was resolved. Analogous indications were also assessed in the MIS group, as appropriate. Indications, baseline, perioperative characteristics, and short-term postoperative outcomes were compared between open and MIS. Results Among 319 ileocolic resections for CD, 45 (14.1%) were open and 274 (85.9%) MIS. Indications for open approach were severe disease, adhesions at previous surgery, history of abdominal sepsis, multifocal and extensive disease, abdominal wall involvement, concomitant open procedures, small bowel dilatation, and anaesthesiologic contraindications (Table 1). In addition, two or more of the above indications were present in 40 patients (89%) in the open group, while only in 6 patients (2%) in the MIS group (p<0.001). Compared to MIS patients, patients undergoing open ileocolic resection were older, with longer CD duration, more previous surgery and preoperative intra-abdominal abscess drainage (Table 2). Nine patients were converted in the MIS group (3.3%). Intraoperatively, open group had more adhesiolysis ≥45 min, more intraoperative complications, more blood loss, more primary stoma, less anastomosis, and longer operative time (Table 3). Postoperatively, they had more overall postoperative complications, ileus, surgical site infections, dehydration, vascular thromboembolism, higher severity by Clavien-Dindo classification, and longer length of stay (Table 4). Conclusion Overall rate of open approach ileocolic resection for CD was 14 % during a 7-years period in a referral centre. Open approach was the only operation performed in cases of abdominal wall involvement, concomitant open procedures, and anaesthesiologic contraindication. In addition, the presence of at least two indications,predicting high technical complexity, may be considered as a no-go for the MIS approach in ileocolic resections for CD.
Awareness, Perceptions, and Literacy Surrounding Hearing Loss and Hearing Rehabilitation Among the Adult Population in the United States
Carlson, Matthew L. , Nassiri, Ashley M. , Marinelli, John P. , Lohse, Christine M. , Sydlowski, Sarah

Mayo Clinic

Otology & Neurotology | January 21, 2022 | Volume: 43 | Issue: 3 | Pages: e323-e330

10.1097/mao.0000000000003473 | PMID 35061637 Get It

Objective: To characterize current awareness, perceptions, and literacy surrounding hearing loss among the adult population in the United States. Study Design: National cross-sectional survey study. Setting: United States. Patients: Adults between 50 and 80 years of age in the United States. Results: Survey respondents included 1,250 adults between the ages of 50 and 80 years, including 500 who indicated at least moderate hearing loss and were using hearing aids and 750 who denied having hearing loss and were not using hearing aids. Only 9% of patients were able to correctly identify what constitutes a “normal” or “average” range for hearing. By comparison, a “normal” range of values for vision, blood pressure, and total cholesterol were identified correctly by 93%, 85%, and 52% of the 1,250 surveyed adults, respectively. When asked to rank the importance of addressing hearing loss within the context of 10 other common health conditions, hearing loss was ranked third to least important. When considering annual health maintenance, respondents indicated they were “very likely” to have an annual physical exam (72%), a cholesterol test (70%), an eye exam (66%), and bring their pet to a veterinarian (59%) over twice as frequently as having their hearing evaluated (27%). When evaluating awareness surrounding associations between hearing loss and other health and social issues, less than one-fourth indicated strong awareness about links between hearing loss and depression, employability and income, fall risk, dementia, and type 2 diabetes. While most patients acknowledge the potential impacts of hearing loss on safety, quality of life, and health, less than half believe that hearing loss is treatable and less than 20% believe that hearing loss is preventable. Conclusion: Despite widespread literacy of what constitutes normal vision, blood pressure, and total cholesterol levels, respondents exhibit substantially poorer understanding of “normal” hearing levels. Most adults believe that few treatment options exist for the management of hearing loss. Underlying the uniformly limited literacy surrounding hearing loss and its treatment options is the adult population's lack of appreciation for the long-term health sequelae of untreated hearing loss.